MBio Diagnostics, Inc. Announces Additional $6 Million in Series B FundingFunding Supports Scaling of Portable On-the-Spot Testing Platform BOULDER, Colo., August 21, 2018-- MBio Diagnostics, Inc., a company leading a new era in rapid, on-the-spot clinical diagnostics and sample testing, announced an additional $6 million in Series B financing led by new and existing investors, including MBio’s recently announced strategic veterinary partner, Heska. The funding supports the refinement of the MBio platform and improvements in manufacturing as the company scales-up to support its commercialization partners.